Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Account Payables: 2018-2024

Historic Change in Account Payables for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to $2.3 million.

  • Eton Pharmaceuticals' Change in Account Payables rose 284.42% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 1129.97%. This contributed to the annual value of $2.3 million for FY2024, which is 4273.58% up from last year.
  • As of FY2024, Eton Pharmaceuticals' Change in Account Payables stood at $2.3 million, which was up 4,273.58% from $53,000 recorded in FY2023.
  • Eton Pharmaceuticals' Change in Account Payables' 5-year high stood at $2.3 million during FY2024, with a 5-year trough of -$570,000 in FY2021.
  • Over the past 3 years, Eton Pharmaceuticals' median Change in Account Payables value was $53,000 (recorded in 2023), while the average stood at $787,667.
  • Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 132.22% in 2021, then spiked by 4,273.58% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Change in Account Payables stood at $1.8 million in 2020, then crashed by 132.22% to -$570,000 in 2021, then spiked by 98.60% to -$8,000 in 2022, then skyrocketed by 762.50% to $53,000 in 2023, then skyrocketed by 4,273.58% to $2.3 million in 2024.